Citação norma APA

Kim, S., Hyeon, J., Cho, I., Ko, Y. H., & Kim, W. S. (2019). Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas. Cancer Res Treat.

Citação norma Chicago

Kim, Seok-Jin, Jiyeon Hyeon, Inju Cho, Young Hyeh Ko, and Won Seog Kim. "Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas." Cancer Res Treat 2019.

Citação norma MLA

Kim, Seok-Jin, et al. "Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas." Cancer Res Treat 2019.

Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.